纳米颗粒
信使核糖核酸
聚合物
纳米技术
化学
材料科学
化学工程
生物化学
复合材料
基因
工程类
作者
Yan Cao,Zongxing He,Qimingxing Chen,Xiaoyan He,Lili Su,Wenxia Yu,Mingming Zhang,Huiying Yang,Xingxu Huang,Jianfeng Li
出处
期刊:Nano Letters
[American Chemical Society]
日期:2022-08-15
卷期号:22 (16): 6580-6589
被引量:38
标识
DOI:10.1021/acs.nanolett.2c01784
摘要
Lipid nanoparticles (LNPs) carrying therapeutic mRNAs hold great promise in treating lung-associated diseases like viral infections, tumors, and genetic disorders. However, because of their thermodynamically unstable nature, traditional LNPs carrying mRNAs need to be stored at low temperatures, which hinders their prevalence. Herein, an efficient lung-specific mRNA delivery platform named five-element nanoparticles (FNPs) is developed in which helper-polymer poly(β-amino esters) (PBAEs) and DOTAP are used in combination. The new strategy endows FNPs with high stability by increasing the charge repulsion between nanoparticles and the binding force of the aliphatic chains within the nanoparticles. The structure–activity relationship (SAR) shows that PBAEs with E1 end-caps, higher degrees of polymerization, and longer alkyl side chains exhibit higher hit rates. Lyophilized FNP formulations can be stably stored at 4 °C for at least 6 months. Overall, a novel delivery platform with high efficiency, specificity, and stability was developed for advancing mRNA-based therapies for lung-associated diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI